Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 1;78(1):8-9.
doi: 10.1097/HEP.0000000000000385. Epub 2023 Mar 28.

Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases

Kara Wegermann  1 , Anna Mae Diehl
Affiliations
Editorial

Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases

Kara Wegermann et al. Hepatology. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Abozaid YJ, Ayada I, van Kleef LA, Vallerga CL, Pan Q, Brouwer WP, et al. Plasma proteomic signature of fatty liver disease: the Rotterdam Study. Hepatology. 2023. doi:10.1097/HEP.0000000000000300. - DOI
    1. Corey KE, Pitts R, Lai M, Loureiro J, Masia R, Osganian SA, et al. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. J Hepatol. 2022;76:25–33.
    1. Niu L, Geyer PE, Wewer Albrechtsen NJ, Gluud LL, Santos A, Doll S, et al. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol Syst Biol. 2019;15:e8793.
    1. Sveinbjornsson G, Ulfarsson MO, Thorolfsdottir RB, Jonsson BA, Einarsson E, Gunnlaugsson G, et al. Multiomics study of nonalcoholic fatty liver disease. Nat Genet. 2022;54:1652–1663.
    1. Kliewer SA, Mangelsdorf DJ. A dozen years of discovery: insights into the physiology and pharmacology of FGF21. Cell Metab. 2019;29:246–253.

LinkOut - more resources